PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancer
Latest Information Update: 12 Apr 2019
At a glance
- Drugs Paclitaxel (Primary) ; Trastuzumab (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil
- Indications Early breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 01 Apr 2019 Results published in the Anticancer Research
- 01 Apr 2019 Status changed to completed as per results published in the Anticancer Research
- 24 Jul 2012 New trial record